Literature DB >> 28318360

Axillary hyperhidrosis: a focused review.

Jason E Sammons1, Amor Khachemoune2.   

Abstract

Axillary hyperhidrosis is characterized by an increased amount of sweat production, localized to the armpits, to compensate for environmental conditions and to control thermoregulation. It affects about 3.12% of the US population. It has a significant effect on one's psychological and physical health, as well as one's occupational life. The objective of this paper is to review the epidemiology, clinical presentation, pathophysiology, histology, genetics, and management and treatment of axillary hyperhidrosis.

Entities:  

Keywords:  Hyperhidrosis; axillary hyperhidrosis; excessive sweating; management of hyperhidrosis

Mesh：

Substances：

Year:  2017        PMID： 28318360     DOI： 10.1080/09546634.2017.1309347

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN： 0954-6634            Impact factor:   3.359


  3 in total

1.  A phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group study of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis.

Authors:  Hiroo Yokozeki; Tomoko Fujimoto; Yoichiro Abe; Masaru Igarashi; Akiko Ishikoh; Tokuya Omi; Hiroki Kanda; Hiroto Kitahara; Miwako Kinoshita; Ichiro Nakasu; Naoko Hattori; Yuki Horiuchi; Ryuji Maruyama; Haruko Mizutani; Yoshiyuki Murakami; Chiharu Watanabe; Akihiro Kume; Takaaki Hanafusa; Masamitsu Hamaguchi; Akira Yoshioka; Yuriko Egami; Keizo Matsuo; Tomoko Matsuda; Motoki Akamatsu; Toshiyuki Yorozuya; Shinichi Takayama
Journal:  J Dermatol       Date:  2021-01-07       Impact factor: 4.005

2.  Conservative Management of Median Nerve Brachial Plexopathy after Microwave-based MiraDry Treatment for Axillary Hyperhidrosis.

Authors:  Frank G Lee; Ahmed M Mansour; Sean J Wallace; Nathan F Miller
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-12-15

3.  A phase III, 52-week, open-label study to evaluate the safety and efficacy of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis.

Authors:  Tomoko Fujimoto; Yoichiro Abe; Masaru Igarashi; Akiko Ishikoh; Tokuya Omi; Hiroki Kanda; Hiroto Kitahara; Miwako Kinoshita; Ichiro Nakasu; Naoko Hattori; Yuki Horiuchi; Ryuji Maruyama; Haruko Mizutani; Yoshiyuki Murakami; Chiharu Watanabe; Akihiro Kume; Takaaki Hanafusa; Masamitsu Hamaguchi; Akira Yoshioka; Yuriko Egami; Keizo Matsuo; Tomoko Matsuda; Motoki Akamatsu; Toshiyuki Yorozuya; Shinichi Takayama; Hiroo Yokozeki
Journal:  J Dermatol       Date:  2021-05-26       Impact factor: 4.005
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.